dexchlorpheniramine
Generic: DEXCHLORPHENIRAMINE MALEATE·Brand: DEXCHLORPHENIRAMINE MALEATE, POLARAMINE, POLMON
dexchlorpheniramine: 1 clinical trial tracked.
dexchlorpheniramine evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about dexchlorpheniramine, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trials (1)
A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Paediatric Patients With Relapsing Remitting Multiple Sclerosis (RRMS) With Disease Activity on Prior Disease Modifying Therapy (DMT)
Primary endpoint: Brain Magnetic Resonance Imaging (MRI) Assessment: Adjusted Number of New or Enlarged T2 Lesions Per Month
Interventionalopen16 enrolledStarted 2017-10Completion 2025-0913 sites · France, Italy, Poland, Russia…Genzyme, a Sanofi Company